BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9038715)

  • 1. T-cell stimulation and cytokine release induced by staphylococcal enterotoxin A (SEA) and the SEAD227A mutant.
    Holzer U; Orlikowsky T; Zehrer C; Bethge W; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Immunology; 1997 Jan; 90(1):74-80. PubMed ID: 9038715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity.
    Lando PA; Dohlsten M; Hedlund G; Brodin T; Sansom D; Kalland T
    Immunology; 1993 Oct; 80(2):236-41. PubMed ID: 7505257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superantigen-staphylococcal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells.
    Holzer U; Bethge W; Krull F; Ihle J; Handgretinger R; Reisfeld RA; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Immunol Immunother; 1995 Aug; 41(2):129-36. PubMed ID: 7656271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
    Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression.
    Mehindate K; Thibodeau J; Dohlsten M; Kalland T; Sékaly RP; Mourad W
    J Exp Med; 1995 Nov; 182(5):1573-7. PubMed ID: 7595227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
    Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
    Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally superantigen-activated peritoneal cytolytic T lymphocytes belong to the CD8+ CD45RC- subset and lyse MHC class II+ tumor cells.
    Hansson J; Ericsson PO; Dohlsten M; Sjögren HO; Kalland T; Hedlund G
    Immunol Lett; 1992 Dec; 34(3):229-36. PubMed ID: 1487309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
    Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
    J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies are capable of directing superantigen-mediated T cell killing of chronic B lymphocytic leukemia cells.
    Gidlöf C; Dohlsten M; Kalland T; Tötterman TH
    Leukemia; 1995 Sep; 9(9):1534-42. PubMed ID: 7544852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial superantigens as anti-tumour agents: induction of tumour cytotoxicity in human lymphocytes by staphylococcal enterotoxin A.
    Lando PA; Hedlund G; Dohlsten M; Kalland T
    Cancer Immunol Immunother; 1991; 33(4):231-7. PubMed ID: 2059967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human natural killer (NK) cells present staphylococcal enterotoxin B (SEB) to T lymphocytes.
    D'Orazio JA; Stein-Streilein J
    Clin Exp Immunol; 1996 May; 104(2):366-73. PubMed ID: 8625534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superantigen-induced lysis of melanoma cells.
    Krull F; Holzer U; Ihle J; Bethge W; Fierlbeck G; Kalland T; Dohlsten M; Niethammer D; Dannecker GE
    Melanoma Res; 1997 Jun; 7(3):214-22. PubMed ID: 9195560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.
    Rosendahl A; Hansson J; Antonsson P; Sékaly RP; Kalland T; Dohlsten M
    Infect Immun; 1997 Dec; 65(12):5118-24. PubMed ID: 9393804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell immunotherapy for human MK-1-expressing tumors using a fusion protein of the superantigen SEA and anti-MK-1 scFv antibody.
    Ueno A; Arakawa F; Abe H; Matsumoto H; Kudo T; Asano R; Tsumoto K; Kumagai I; Kuroki M; Kuroki M
    Anticancer Res; 2002; 22(2A):769-76. PubMed ID: 12014649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.
    Riesbeck K; Billström A; Tordsson J; Brodin T; Kristensson K; Dohlsten M
    Clin Diagn Lab Immunol; 1998 Sep; 5(5):675-82. PubMed ID: 9729535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synovial fibroblasts as target cells for staphylococcal enterotoxin-induced T-cell cytotoxicity.
    Kraft M; Filsinger S; Krämer KL; Kabelitz D; Hänsch GM; Schoels M
    Immunology; 1998 Jan; 93(1):20-5. PubMed ID: 9536114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.